Severity
Low
FDA Drug recall · Reported August 15, 2018
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label
Right Value Drug Stores, Inc. recalled Testosterone 200 mg Pellet, Rx only, Carie Boyd's Prescription Shop 122 Grapevine Hwy., H… - a low-severity action.
Testosterone 200 mg Pellet, Rx only, Carie Boyd's Prescription Shop 122 Grapevine Hwy., H… was recalled by Right Value Drug Stores, Inc. in August 15, 2018. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label. Check the official notice for the remedy. Verify recall #D-1047-2018 with the FDA Drug before acting.
The recall
Right Value Drug Stores, Inc. issued this low-severity FDA Drug recall-Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label.
Sourced from official FDA Drug enforcement records. Verify recall #D-1047-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1047-2018) was formally reported on August 15, 2018, with the manufacturer initiating the action on July 26, 2018. It is classified under Low severity (Class III), with a current status of Terminated. Right Value Drug Stores, Inc. is listed as the recalling firm, operating out of Hurst, TX. Federal records list the affected scope as 4800 pellets.
The documented reason for this recall is: Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label Distribution data in the federal record shows the product reached: Nationwide with the United States. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
4800 pellets
Related Recalls
6
5 from same agency
Testosterone 200 mg Pellet, Rx only, Carie Boyd's Prescription Shop 122 Grapevine Hwy., Hurst, TX 76054, 800-930-4361
Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-1047-2018 |
| Date reported | August 15, 2018 |
| Date initiated | July 26, 2018 |
| Recalling firm | Right Value Drug Stores, Inc. |
| Firm location | Hurst, TX |
| Affected scope | 4800 pellets |
| Distribution | Nationwide with the United States |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 15, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.